Heterozygous variant of CYP2C8*3 is a protective factor for developing post-ERCP pancreatitis.

Autor: de Jong MJ; Department of Gastroenterology and Hepatology, Radboud university medical center, Nijmegen, The Netherlands; Department of Research and Development, St. Antonius Hospital, Nieuwegein, The Netherlands. Electronic address: Mike.deJong@radboudumc.nl., Kuipers RN; Department of Gastroenterology and Hepatology, Radboud university medical center, Nijmegen, The Netherlands; Department of Research and Development, St. Antonius Hospital, Nieuwegein, The Netherlands., Drenth JP; Department of Gastroenterology and Hepatology, Radboud university medical center, Nijmegen, The Netherlands; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Te Morsche RH; Department of Gastroenterology and Hepatology, Radboud university medical center, Nijmegen, The Netherlands., van Delft F; Department of Gastroenterology and Hepatology, Radboud university medical center, Nijmegen, The Netherlands., Siersema PD; Department of Gastroenterology and Hepatology, Radboud university medical center, Nijmegen, The Netherlands; Department of Gastroenterology and Hepatology, Erasmus MC - University Medical Center, Rotterdam, The Netherlands.

Publikováno v: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2024 Dec 14. Date of Electronic Publication: 2024 Dec 14.